Folding-Mediated DNA Delivery by α-Helical Amphipathic Peptides

Area of Science:

• Biomaterials Science
• Gene Therapy Delivery
• Molecular Biology

Background:

• Gene therapy relies on efficient delivery of genetic material using specialized biomaterials.
• Peptide transfection systems are a key class of these biomaterials, with several commercialized options.
• A comparative analysis of peptide sequences alone for DNA delivery efficacy has been lacking.

Purpose of the Study:

• To cross-compare commercial and experimental peptide transfection reagents from the same structural family.
• To assess factors influencing DNA delivery efficacy, including cell uptake, gene expression, cytotoxicity, and DNA complexation.
• To identify the common determinant for DNA complexation and delivery by these peptide reagents.

Main Methods:

• Cross-comparison of commercial and experimental helical amphiphile peptide transfection reagents.
• Assessment of DNA complexation capabilities.
• Evaluation of cell uptake and gene expression levels.
• Cytotoxicity assays.
• Analysis of peptide-DNA co-folding.

Main Results:

• Peptide reagents of the same structural family exhibit similar characteristics and limitations, irrespective of sequence variations.
• Functional DNA delivery is independent of specific peptide sequences.
• The ability of reagents to co-fold with DNA is the primary mediator of DNA complexation and delivery.
• Peptide folding was identified as the common determinant for effective DNA delivery.

Conclusions:

• Peptide folding is the critical factor for successful DNA complexation and delivery in gene therapy applications.
• The efficacy of peptide transfection reagents is primarily governed by their structural co-folding ability with DNA, rather than sequence alone.
• This finding provides a unified understanding for the development of next-generation peptide-based gene delivery systems.